standard group (IMRT only) | experimental group (IMRT + C12) | |
---|---|---|
number of patients | 37 | 58 |
deceased | 30 (81%) | 26 (45%) |
mean OS (months) | 68.4 | 78.3 |
local relapse | 23 (62%) | 29 (50%) |
surgery | 4 (17%) | 17 (59%) |
re-RT | 14 (61%) | 13 (45%) |
re-RT as C12 | 1 (8%) | 8 (62%) |
chemotherapy | 1 (4%) | |
distant metastases | 16 (43%) | 22 (38%) |
chemotherapy | 16 (100%) | 21 (95%) |
palliative RT | 5 (31%) | 8 (36%) |